Skip to main content

Want a detailed portfolio tracker?

Amneal Pharmaceuticals (AMRX) Income Statement (2017 - 2026)

Income Statement report data from Jun 30, 2017 to Mar 31, 2026 for Amneal Pharmaceuticals (AMRX).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017
Revenue and COGS
Total Revenue
723M
(-11.27%)
814M
(+3.80%)
785M
(+8.28%)
725M
(+4.18%)
695M
(-4.80%)
731M
(+3.99%)
702M
(+0.10%)
702M
(+6.46%)
659M
(+6.84%)
617M
(-0.49%)
620M
(+3.50%)
599M
(+7.45%)
558M
(-8.56%)
610M
(+11.77%)
546M
(-2.47%)
559M
(+12.40%)
498M
(-7.31%)
537M
(+1.57%)
529M
(-1.21%)
535M
(+8.51%)
493M
(-3.32%)
510M
(-1.78%)
519M
(+11.76%)
465M
(-6.79%)
499M
(+25.47%)
397M
(+5.04%)
378M
(-6.51%)
405M
(-9.30%)
446M
(-10.33%)
498M
(+4.42%)
476M
(+15.15%)
414M
(+50.37%)
275M
(+8.03%)
255M
(-1.98%)
260M
Gross Profit
320M
(+7.71%)
297M
(+8.48%)
274M
(-4.29%)
286M
(+11.86%)
256M
(-2.66%)
263M
(-2.48%)
270M
(+7.85%)
250M
(+4.99%)
238M
(+25.41%)
190M
(-18.36%)
233M
(+5.69%)
220M
(+23.47%)
178M
(-17.27%)
215M
(+10.89%)
194M
(-3.14%)
201M
(+14.87%)
175M
(+4.91%)
166M
(-16.18%)
199M
(-6.58%)
213M
(+10.93%)
192M
(+14.66%)
167M
(+25.06%)
134M
(-7.38%)
144M
(-21.40%)
184M
(+66.47%)
110M
(+102.52%)
54M
(-48.29%)
105M
(+26.69%)
83M
(-57.04%)
193M
(-3.35%)
200M
(+12.23%)
178M
(+23.31%)
145M
(+7.10%)
135M
(+9.12%)
124M
Operating Expenses
Research And Development
38M
(+10.22%)
35M
(-45.04%)
63M
(+32.09%)
48M
(+19.78%)
40M
(-26.22%)
54M
(-11.18%)
61M
(+69.49%)
36M
(-8.27%)
39M
(-14.73%)
46M
(+11.38%)
41M
(+9.47%)
38M
(-2.30%)
39M
(-7.68%)
42M
(-16.58%)
50M
(-1.00%)
51M
(-3.88%)
53M
(+1.79%)
52M
(+6.01%)
49M
(-7.43%)
53M
(+9.71%)
48M
(-9.88%)
53M
(+20.08%)
45M
(-2.30%)
46M
(+25.26%)
36M
(-24.29%)
48M
(+26.02%)
38M
(-20.60%)
48M
(-10.84%)
54M
(-6.00%)
57M
(+35.30%)
42M
(-15.87%)
50M
(+13.87%)
44M
(+6.99%)
41M
(-12.42%)
47M
Selling General And Administrative
139M
(-5.19%)
146M
(+6.27%)
138M
(+10.90%)
124M
(+5.06%)
118M
(-8.08%)
129M
(+8.43%)
119M
(+1.91%)
116M
(+3.43%)
113M
(+3.30%)
109M
(-3.55%)
113M
(+7.05%)
106M
(+3.40%)
102M
(-0.06%)
102M
(+2.09%)
100M
(+1.28%)
99M
(+0.14%)
99M
(+1.49%)
97M
(+6.37%)
91M
(+6.08%)
86M
(-5.04%)
91M
(+7.13%)
85M
(+1.89%)
83M
(+2.69%)
81M
(+3.80%)
78M
(+5.26%)
74M
(+16.11%)
64M
(-5.17%)
67M
(-20.32%)
84M
(+18.53%)
71M
(-5.63%)
75M
(+34.80%)
56M
(+122.93%)
25M
(-8.45%)
27M
(+1.86%)
27M
Operating Expenses
177M
(-2.23%)
181M
(-9.89%)
201M
(+16.80%)
172M
(+8.78%)
158M
(-13.46%)
183M
(+1.76%)
180M
(+17.88%)
153M
(+0.41%)
152M
(-2.06%)
155M
(+0.46%)
154M
(+7.68%)
143M
(+1.83%)
141M
(-2.28%)
144M
(-4.15%)
150M
(+0.51%)
150M
(-1.26%)
151M
(+1.58%)
149M
(+6.26%)
140M
(+0.94%)
139M
(+0.08%)
139M
(+0.55%)
138M
(+8.23%)
128M
(+0.89%)
127M
(+10.63%)
114M
(-6.36%)
122M
(+19.83%)
102M
(-11.60%)
115M
(-16.62%)
138M
(-30.11%)
198M
(+67.91%)
118M
(+10.81%)
106M-69M
(-7.23%)
74M
Depreciation And Amortization
-57M---63M---66M---68M---61M---60M---63M---32M
(+82.09%)
17M
(+12.36%)
15M-11M
(+10.67%)
9.65M
Operating Income
Operating Income
142M
(+26.55%)
112M
(+59.27%)
70M
(-36.84%)
111M
(+10.98%)
100M
(+32.41%)
76M
(-14.66%)
89M
(-6.98%)
95M-10.75M14M
(-81.24%)
76M
(-5.53%)
80M
(+132.45%)
34M
(-4.39%)
36M
(-18.76%)
44M-198.62M23M
(+108.50%)
11M
(-60.80%)
29M
(-57.51%)
67M
(+46.20%)
46M
(+127.50%)
20M
(+727.05%)
2.44M
(-77.30%)
11M
(-81.40%)
58M-23.13M
(-79.40%)
-112.27M
(+493.71%)
-18.91M
(-79.96%)
-94.36M23M
(-68.78%)
75M-181.06M64M
(-19.30%)
79M
(+76.57%)
45M
Ebit
142M
(+26.55%)
112M
(+59.27%)
70M
(-36.84%)
111M
(+10.98%)
100M
(+32.41%)
76M
(-14.66%)
89M
(-6.98%)
95M-10.75M14M
(-81.24%)
76M
(-5.53%)
80M
(+132.45%)
34M
(-4.39%)
36M
(-18.76%)
44M-198.62M23M
(+108.50%)
11M
(-60.80%)
29M
(-57.51%)
67M
(+46.20%)
46M
(+127.50%)
20M
(+727.05%)
2.44M
(-77.30%)
11M
(-81.40%)
58M-23.13M
(-79.40%)
-112.27M
(+493.71%)
-18.91M
(-79.96%)
-94.36M23M
(-68.78%)
75M-181.06M64M
(-19.30%)
79M
(+76.57%)
45M
EBITDA
64M
(-84.24%)
409M-20.99M39M
(+53.71%)
25M
(-93.48%)
384M
(+10848.43%)
3.51M
(-63.48%)
9.61M-85.49M257M
(+3281.73%)
7.61M
(-36.00%)
12M-6.27M223M-3.04M
(-98.71%)
-234.78M
(+1811.89%)
-12.28M171M-3.73M33M
(+148.97%)
13M
(-92.83%)
183M-21.50M
(-2.18%)
-21.98M12M-231.15M125M-22.60M
(-59.87%)
-56.31M118M
(+28.47%)
92M-165.61M360K
(-99.60%)
89M
(+64.85%)
54M
Other Income / Expenses
Other Non Operating Income
740K
(-95.52%)
17M
(+1232.26%)
1.24M
(-22.50%)
1.60M
(+207.69%)
520K
(-95.59%)
12M
(+898.31%)
1.18M
(-72.94%)
4.36M
(+7.13%)
4.07M
(-50.61%)
8.24M
(+350.27%)
1.83M
(+335.71%)
420K
(-90.39%)
4.37M
(-76.33%)
18M
(+223.29%)
5.71M
(-17.72%)
6.94M
(+227.36%)
2.12M
(-86.17%)
15M
(+296.12%)
3.87M
(-3.97%)
4.03M
(+410.13%)
790K
(-69.50%)
2.59M
(+187.78%)
900K
(+57.89%)
570K
(-9.52%)
630K
(-57.14%)
1.47M
(+226.67%)
450K
(+200.00%)
150K
(-86.49%)
1.11M
(-5.93%)
1.18M-1.01M790K
(-16.84%)
950K-90.00K
(+12.50%)
-80.00K
Net Income
Income Before Tax
80M
(+45.15%)
55M-5.22M52M
(+37.93%)
37M-15.32M15M
(-24.45%)
20M-75.52M
(-9.51%)
-83.46M23M
(-22.59%)
30M-9.43M
(+23.27%)
-7.65M2.18M-232.73M
(+2246.07%)
-9.92M
(-39.22%)
-16.32M
(+700.00%)
-2.04M35M
(+133.69%)
15M-5.48M
(-74.97%)
-21.89M
(+0.60%)
-21.76M13M-57.11M26M-56.23M
(-57.78%)
-133.18M
(+799.26%)
-14.81M23M-262.51M52M
(+97.19%)
26M
(-33.38%)
40M
Income Tax Expense
2.18M
(-61.48%)
5.66M-23.35M16M
(+25.10%)
13M
(+137.45%)
5.42M
(+47.68%)
3.67M
(+1.38%)
3.62M
(-41.23%)
6.16M
(-37.65%)
9.88M-2.08M
(+10300.00%)
-20.00K670K-1.80M4.57M
(-37.82%)
7.35M-3.46M4.14M
(+2.22%)
4.05M
(+52.83%)
2.65M
(+636.11%)
360K
(-75.84%)
1.49M
(+964.29%)
140K
(-93.61%)
2.19M-108.17M7.79M
(-98.00%)
390M-5.70M
(-32.38%)
-8.43M5.52M
(+8.02%)
5.11M-12.42M360K-740.00K1.85M
Net Income From Continuing Operations
62M
(+77.48%)
35M
(+1380.17%)
2.37M
(-89.43%)
22M
(+83.77%)
12M-31.08M
(+19325.00%)
-160.00K5.99M-91.64M
(-7.11%)
-98.65M9.68M
(-18.79%)
12M-6.94M
(-42.31%)
-12.03M
(+58.08%)
-7.61M
(-96.86%)
-242.13M
(+2645.24%)
-8.82M
(-59.54%)
-21.80M
(+180.21%)
-7.78M30M
(+135.22%)
13M-6.83M
(-68.44%)
-21.64M
(-10.43%)
-24.16M120M-273.78M
(+3.31%)
-265.01M
(+1468.11%)
-16.90M
(-64.70%)
-47.88M
(+445.95%)
-8.77M6.89M-17.86M---
Net Income
62M
(+77.48%)
35M
(+1380.17%)
2.37M
(-89.43%)
22M
(+83.77%)
12M-31.08M
(+19325.00%)
-160.00K5.99M-91.64M
(-7.11%)
-98.65M9.68M
(-18.79%)
12M-6.94M
(-42.31%)
-12.03M
(+58.08%)
-7.61M
(-96.86%)
-242.13M
(+2645.24%)
-8.82M
(-59.54%)
-21.80M
(+180.21%)
-7.78M30M
(+135.22%)
13M-6.83M
(-68.44%)
-21.64M
(-10.43%)
-24.16M120M-273.78M
(+3.31%)
-265.01M
(+1468.11%)
-16.90M
(-64.70%)
-47.88M
(+445.95%)
-8.77M6.89M-17.86M---
Comprehensive Income Net Of Tax
61M
(+126.64%)
27M-6.08M11M-8.03M
(-94.65%)
-150.05M
(+244.94%)
-43.50M
(+5858.90%)
-730.00K
(-99.12%)
-83.00M
(-34.67%)
-127.04M5.46M
(-66.36%)
16M-13.18M
(-86.14%)
-95.11M8.98M-119.59M22M
(-17.96%)
27M-3.47M15M
(+8.40%)
14M
(-72.30%)
50M-10.57M
(-42.15%)
-18.27M82M-353.42M
(+34.47%)
-262.82M
(+1244.35%)
-19.55M
(-55.77%)
-44.20M
(+89.37%)
-23.34M3.57M-20.27M---